AGN acquires RPRX for $0.67/sh in cash: https://globenewswire.com/news-release/2017/12/12/1252970/0/en/Repros-Therapeutics-Inc-Announces-Acquisition-by-Allergan-plc.html Although the buyout is a 43% premium to yesterday's closing price, this is essentially a takeunder with a nominal deal price of only $27M. RPRX has been a colossal failure for the past decade, as many readers of this board know. No CC.